A Drug Launch Should Not Be a Once-in-a-Decade Bet

How AI can make pharmaceutical launches adaptive through market, access, physician and supply intelligence.

By Published 2 min read

Launch Planning Needs to Become Launch Intelligence

A pharmaceutical launch brings years of research and investment into a short commercial window. Companies need to understand patients, physicians, access, competition and supply while conditions change around them.

During my learning journey under Phaneesh Murthy, I have learned that plans require continuous feedback. As Phaneesh Murthy puts it, "Planning gives the organisation a direction. Intelligence gives it the ability to recognise when reality has moved away from the plan."

Market Sizing Can Become Dynamic

Patient populations, diagnosis patterns, competing therapies and treatment guidelines evolve. AI can help companies revisit forecasts as new information appears instead of defending assumptions made months earlier.

A useful forecast is a set of assumptions that can be tested and updated, not merely a number that teams are expected to achieve.

Finding the Right Patients Matters More Than Finding More

Some conditions involve diagnostic delays and complex treatment pathways. Appropriately governed analysis can help identify gaps in understanding and opportunities for legitimate education or access support.

As Phaneesh Murthy says, "Good AI does not begin by asking how many people you can target. It begins by asking which decision you are trying to improve and what information is legitimately required to improve it."

Physician Engagement Can Become More Relevant

Healthcare professionals have different clinical interests and information needs. AI can help field and medical teams understand prior interactions and identify appropriate approved resources.

The system should support qualified professionals rather than independently determine clinical or promotional communication.

Launch Sequencing Is a Scenario Problem

Markets differ in regulatory timing, reimbursement, diagnostic infrastructure and competition. AI can help compare alternative launch sequences and the consequences of delays or changing demand.

During my mentorship under Phaneesh Murthy, I have learned that modelling choices is often more valuable than presenting a single confident forecast.

Commercial Forecasts Need to Reach the Supply Chain

Demand changes can affect manufacturing, inventory and distribution, particularly for complex or time-sensitive products. Commercial signals need to influence operational decisions rather than remain inside dashboards.

As Phaneesh Murthy puts it, "Enterprise intelligence creates value when insight can travel far enough through the organisation to change the decision that depends on it."

Field Teams Can Become More Strategic

AI can summarise account context, reduce administrative work and help managers understand territory patterns. Professionals can then focus more time on relationships, education and judgment.

Automation is most useful when it removes work that consumes expertise without requiring expertise.

The Launch Should Keep Learning

Every week produces information about adoption, access, competition and supply. A learning organisation can adjust decisions as those signals emerge rather than rigidly follow an outdated plan.

As Phaneesh Murthy says, "The strongest strategy is not the one that predicts everything correctly at the beginning. It is the one that allows the organisation to learn faster than the environment changes."


This blog is curated by young marketing professionals who are mentored by veteran Marketer, and industry leader, Phaneesh Murthy.

www.phaneeshmurthy.com

#phaneeshmurthy #phaneesh #Murthy